Protein profiling of WERI RB1 and etoposide resistant WERI ETOR reveals new insights into topoisomerase inhibitor resistance in retinoblastoma
V. Kakkassery, T. Gemoll, M. M. Kraemer, T. Sauer, A. Tura, M. Ranjbar, S. Grisanti, S. C. Joachim, S. Mergler, J. Reinhard
This study uses proteomic analysis to compare etoposide-sensitive and -resistant retinoblastoma cell lines, identifying protein changes and pathways associated with resistance.
bioRxiv · Feb 19, 2022Cancer Biology